Epithelial ion channels and transporter proteins have physiologically important roles throughout the length of the nephron. Discovering the molecular identities of tubular epithelial cell proteins and their functional roles has increased understanding of both renal physiology and tubular diseases. Defects in tubular handling of solutes may present with nephrocalcinosis or nephrolithiasis, rickets, acid-base, electrolyte or blood pressure disturbances. Biochemical analysis of both serum and urine, together with clinical history and examination, remain fundamental for their diagnosis, whilst understanding of underlying molecular mechanisms allows appropriate management.
References
1.
NielsenSKwonTHChristensenBMPromeneurDFrokiaerJMarplesD.Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol1999;10: 647–63.
2.
PennyMDOleeskyDA. Renal tubular acidosis. Ann Clin Biochem1999;36: 408–22.
3.
PearceSHThakkerRV. The calcium-sensing receptor: insights into extracellular calcium homeostasis in health and disease. J Endocrinol1997;154: 371–8.
4.
NordenAGScheinmanSJDeschodt-LanckmanMMLapsleyMNortierJLThakkerRVTubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases. Kidney Int2000;57: 240–9.
LoweCUTerreyMMcLachlanEA. Organicaciduria, decreased renal ammonia production, hydrophthalmus, and mental retardation. Am J Dis Child1952;83: 164–84.
8.
AttreeOOlivosIMOkabeIBaileyLCNelsonDLLewisRAThe Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphates-phosphatase. Nature1992;358: 239–42.
9.
ZhangXJeffersonABAuethavekiatVMajerusPW. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc Natl Acad Sci USA1995;92: 4853–6.
10.
SuchySFLinTHorwitzJAO'BrienWENussbaumRL. First report of prenatal biochemical diagnosis of Lowe syndrome. Prenatal Diagn1998;18: 1117–21.
11.
ZhangXHartzPAPhilipERacusenLCMajerusPW. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate. J Biol Chem1998;273: 1574–82.
12.
UngewickellAJMajerusPW. Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome. Proc Natl Acad Sci USA1999;96: 13342–4.
13.
TanziREPetrukhinKChernovIPellequerJLWascoWRossBThe Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet1993;5: 344–50.
14.
SaitoT.Presenting symptoms and natural history of Wilson disease. Eur J Pediatr1987;146: 261–5.
15.
AziziEEshelGAladjemM.Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease. Eur J Pediatr1989;148: 548–9.
16.
ChowrimootooGFScowcroftHSeymourCA. Caeruloplasmin isoforms in Wilson's disease in neonates. Arch Dis Child Fetal Neonatal Ed1998;79: F198–F201.
17.
WrongOMNordenAGFeestTG. Dent's disease: a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. Q J Med1994;87: 473–93.
18.
LloydSEPearceSHFisherSESteinmeyerKSchwappachBScheinmanSJA common molecular basis for three inherited kidney stone diseases. Nature1996;379: 445–9.
19.
GuntherWLuchowACluzeaudFVandewalleAJentschTJ. CIC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci USA1998;95: 8075–80.
20.
PiwonNGuntherWSchwakeMBoslMRJentschTJ. CIC-5 CI-channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature2000;408: 369–73.
21.
ReinhartSCNordenAGLapsleyMThakkerRVPangJCharacterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol1995;5: 1451–61.
22.
RudinA.Banter's syndrome: a review of 28 patients followed for ten years. Acta Med Scand1988;224: 165–71.
23.
SieckUVOhlssonA.Fetal polyuria and hydramnios associated with Banter's syndrome. Obstel Gynecol1984;63: 22S–24S.
24.
BartterFCPronovePGillJRMacCardleRC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalaemic alkalosis. Am J Med1962;33: 811–28.
25.
SimonDBKaretFEHamdanJMDi PietroASanjadSALiftonRP. Banter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet1996;13: 183–8.
26.
SimonDBKaretFERodriguez-SorianoJHamdanJHDiPietroATrachtmanHGenetic heterogeneity of Bartter's syndrome revealed by mutations in the K(+) channel, ROMK. Nat Genet1996;14: 152–6.
27.
SimonDBBindraRSMansfieldTANelson-WilliamsCMendoncaEStoneRMutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet1997;17: 171–8.
28.
BettinelliABianchettiMGGirardinECaringellaACecconiMAppianiACUse of calcium excretion values to distinguish two forms of primary renal tubular hypokalaemic alkalosis: Bartter and Gitelman syndromes. J Pediatr1992;120: 38–43.
29.
KurtzI.Molecular pathogenesis of Bartter's and Gitelman's syndromes. Kidney Int1998;54: 1396–410.
30.
KonradMVollmerMLemminkHHVan Den HeuvelLPWJJeckNVargas-PoussouRMutations in the chloride channel gene CLCNKB as a cause of classic Bartter's syndrome. J Am Soc Nephrol2000;11: 1449–59.
31.
JeckNKonradMPetersMWeberSBonzelKESeyberthHW. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res2000;48: 754–8.
32.
SieckUVOhlssonA.Fetal polyuria and hydramnios associated with Bartter's syndrome. Obstet Gynecol1984;63: 225–45.
33.
MassaGProesmansWDevliegerHVander-bergheKVan AsscheAEggermontE.Electrolyte composition of the amniotic fluid in Bartter's syndrome. Eur J Obstet Gynecol Reprod Biol1987;24: 335–40.
34.
ShalevHOhalyMMeiznerICarmiR.Prenatal diagnosis of Bartter's syndrome. Prenat Diagn1994;14: 996–8.
35.
MatsushitaYSuzukiYOyaNKajiuraSOkajimaKUemuraOBiochemical examination of mother's urine is useful for prenatal diagnosis of Bartter syndrome. Prenat Diagn1999;19: 671–3.
36.
SmithLGKirshonBCollonDB. Indomethacin treatment for polyhydramnios and subsequent infantile nephrogenic diabetes insipidus. Am J Obstet Gynecol1990;163: 98–9.
37.
HenéRJKoomansHADorhout MeesEJv d StolpeAVerhoefGEBoerP.Correction of hypokalaemia in Bartter's syndrome by enalapril. Am J Kidney Dis1987;9: 200–5.
38.
SeidelCReinalterSSeyberthHWSchärerK.Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol1995;9: 723–8.
39.
KletaRBasogluCKuwertz-BrokingE.New treatment options for Bartter's syndrome. N Engl J Med2000;343: 661–2.
40.
GitelmanHJGrahamJBWeltLG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physician1966;79: 221–35.
41.
SimonDBNelson-WilliamsCBiaMJEllisonDKaretFEMolinaAMGitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazidesensitive Na-Cl cotransporter. Nat Genet1996;12: 24–30.
42.
GesekFAFriedmanPA. Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J Clin Invest1992;90: 429–38.
43.
SimonDBLiftonRP. The molecular basis of inherited hypokalaemic alkalosis: Bartter's and Gitelman's syndrome. Am J Physiol1996;271: F961–F966.
44.
LiawLCBanerjeeKCoulthardMG. Dose related growth response to indomethacin in Gitelman syndrome. Arch Dis Child1999;81: 508–10.
45.
PragaMVaraJGonzalez-ParraEAndresAAlamoCAraqueAFamilial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int1995;47: 1419–25.
46.
EvansRACarterJNGeorgeCRWallsRSNewlandRCMcDonnellGDThe congenital ‘magnesium-losing kidney’. Report of two patients. Q J Med1981;50: 39–52.
47.
SimonDBLuYChoateKAVelazquezHAl-SabbanEPragaMParacellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science1999;285: 103–6.
48.
BenignoVCanonicaCSBettinelliAvon VigierROTruttmanACBianchettiMG. Hypomagnesaemia-hypercalciuria-nephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant2000;15: 605–10.
49.
LiddleGWBledsoeTCoppageWS. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physician1963;76: 199–213.
50.
FindlingJWRaffHHanssonJHLiftonRP. Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab1997;82: 1071–4.
51.
ShimketsRAWarnockDGBositisCMNelson-WilliamsCHanssonJHSchambelanMLiddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell1994;79: 407–14.
52.
SchildLCanessaCMShimketsRAGautschiILiftonRPRossierBC. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci USA1995;92: 5699–703.
53.
SnyderPMPriceMPMcDonaldFJAdamsCMVolkKAZeiherBGMechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel. Cell1995;83: 969–78.
54.
HanssonJHSchildLLuYWilsonTAGautschiIShimketsRA de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci USA1995;92: 11495–9.
55.
SuYRRutkowskiMPKlankeCAWuXCuiYPunRYA novel variant of the beta-subunit of the amiloride-sensitive sodium channel in African Americans. J Am Soc Nephrol1996;7: 2543–9.
56.
BakerEHDongYBSagnellaGARothwellMOnipinlaAKMarkanduNDAssociation of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet1998;351: 1388–92.
57.
WangCChanTKYeungRTCoghlanJPScogginsBAStockigtJR. The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome. J Clin Endocrinol Metab1981;52: 1027–32.
58.
CheekDBPerryJW. A salt wasting syndrome of infancy. Arch Dis Child1958;33: 252–6.
59.
RoslerATheodorRGazitEBiochisHRabinowitzD.Salt wasting, raised plasma-renin activity, and normal or high plasma aldosterone: a form of pseudohypoaldosteronism. Lancet1973;i: 959–62.
60.
HanukogluA.Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab1991;73: 936–44.
61.
KuhnleUNielsenMDTietzeHUSchroeterCHSchlampDBossonDPseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects. J Clin Endocrinol Metab1990;70: 638–41.
62.
ChangSSGrunderSHanukogluARoslerAMathewPMHanukogluIMutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet1996;12: 248–53.
63.
HanukogluABistritzerTRakoverYMandelbergA.Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr1994;125: 752–5.
64.
GellerDSRodriguez-SorianoJVallo BoadoASchifterSBayerMChangSSMutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet1998;19: 279–81.
65.
AraiKTsigosCSuzukiYIronyIKarlMListwakSPhysiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy. J Clin Endocrinol Metab1994;79: 1019–23.
66.
SchambelanMSebastianARectorFCJr.Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reahsorption. Kidney Int1981;19: 716–27.
67.
GordonRD. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension1986;8: 93–102.
68.
MansfieldTASimonDBFarfelZBiaMTucciJRLebelMMultilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes lq31-42 and 17p11-q21, Nat Genet1997;16: 202–5.
69.
Disse-NicodemeSAchardJMDesitterIHouotAMFournierACorvolPA new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet2000;67: 302–10.
